Company profile

Financière de Tubize is a holding company that owns 35% of the listed biopharmacy group UCB.

Source: Cofisem - Last Update: 31 Aug 2020
Key Executives
Chief Executive Officer Anne Sophie Pijcke
Investor Relations Director Anne Sophie Pijcke
Source: Cofisem - Last Update: 17 Apr 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Investment revenues 286,072 288,251 272,233 187,423 219,768
Personnal costs
Operating income 284,955 286,107 271,292 180,301 210,058
Capital gain from disposals
Income tax 19,760 885 -2,468
Net income 283,704 285,156 285,934 181,186 212,526
Net consolidated income (Group share) 283,704 285,156 285,934 181,186 212,526
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 31 Aug 2020
Shareholder information
Free float 43.15 %
Financière Eric Janssen SRL 23.62 %
Daniel Janssen 13.21 %
Altai Invest SA 11.22 %
Barnfin SA 8.77 %
Source: Cofisem - Last Update: 17 Apr 2020

Financial analysis

Equity research report, in partnership with Morningstar

View Report

Address

Financière de Tubize S.A.

Allée de la Recherche 60
BE-1070 Bruxelles, Bruxelles-Capitale
Belgium
Phone number: +32 (0)476 490 844
Source: Cofisem - Last Update: 31 Aug 2020

Contact

ANNE SOPHIE PIJCKE
Phone number: +32 4 77 45 27 13
Source: Financière de Tubize S.A. - Last Update: 31 Aug 2020